LIFEVANTAGE CORP Dividends Per Share
LIFEVANTAGE CORP (LFVN) reported Dividends Per Share of $0.04 per share for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-02-04
- LIFEVANTAGE CORP common stock, dividends, per share, declared for the quarter ending 2025-12-31 was $0.04, a 12.50% increase year-over-year.
- LIFEVANTAGE CORP common stock, dividends, per share, declared for the quarter ending 2025-09-30 was $0.04, a 12.50% increase year-over-year.
- LIFEVANTAGE CORP common stock, dividends, per share, declared for the quarter ending 2025-03-31 was $0.04.
- LIFEVANTAGE CORP common stock, dividends, per share, declared for the quarter ending 2024-12-31 was $0.04.
| Period end | Common Stock, Dividends, Per Share, Declared | Common Stock, Dividends, Per Share, Declared 1 month | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.04 10-Q · filed 2026-02-04 | $0.09 derived: sum of 2 quarters · filed 2026-02-04 | |||
| 2025-09-30 | $0.04 10-Q · filed 2026-02-04 | ||||
| 2025-03-31 | $0.04 10-Q · filed 2025-05-06 | $0.08 derived: sum of 2 quarters · filed 2025-05-06 | $0.12 derived: sum of 3 quarters · filed 2025-05-06 | ||
| 2024-12-31 | $0.04 10-Q · filed 2025-02-05 | $0.08 derived: sum of 2 quarters · filed 2025-02-05 | |||
| 2024-09-30 | $0.04 10-Q · filed 2024-10-29 | ||||
| 2022-11-30 | $0.03 10-Q · filed 2023-02-02 | ||||
| 2022-08-31 | $0.03 10-Q · filed 2023-02-02 | ||||
| 2022-05-31 | $0.03 10-K · filed 2022-08-23 | ||||
| 2022-05-03 | $0.03 10-K · filed 2022-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |